|
DDX31 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64279700953784E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.77395900588817E-14 |
| Normal-vs-Stage2 |
1.40659994762871E-09 |
| Normal-vs-Stage3 |
1.63191682389652E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
1.678800E-01 |
| Stage1-vs-Stage3 |
2.993800E-01 |
| Stage1-vs-Stage4 |
7.83370000000394E-05 |
| Stage2-vs-Stage3 |
6.543500E-02 |
| Stage2-vs-Stage4 |
4.982700E-04 |
| Stage3-vs-Stage4 |
8.937900E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.32116539930394E-14 |
| Normal-vs-AfricanAmerican |
4.59519999829183E-09 |
| Normal-vs-Asian |
1.8695045511663E-12 |
| Caucasian-vs-AfricanAmerican |
4.083200E-01 |
| Caucasian-vs-Asian |
7.858400E-01 |
| AfricanAmerican-vs-Asian |
5.562200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99840144432528E-15 |
| Normal-vs-Female |
1.66999747364116E-12 |
| Male-vs-Female |
1.112580E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62825308791525E-12 |
| Normal-vs-Age(41-60Yrs) |
4.03010957938932E-13 |
| Normal-vs-Age(61-80Yrs) |
5.99520433297585E-15 |
| Normal-vs-Age(81-100Yrs) |
1.018900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.173500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.288400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.729200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.182100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.210800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.944000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.538300E-03 |
| Classical-VS-Follicular |
1.062040E-01 |
| Classical-VS-Other |
9.964600E-01 |
| Classical-VS-Normal |
5.18474152499948E-14 |
| Tall-VS-Follicular |
5.376700E-04 |
| Tall-VS-Other |
3.770400E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
6.169600E-01 |
| Follicular-VS-Normal |
2.42250663973209E-12 |
| Other-VS-Normal |
5.960100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92246218944092E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
9.6455999999967E-05 |
|
|
